Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Preclinical CRO Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global Preclinical CRO Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Bioanalysis and DMPK Studies 1.4.3 Toxicology Testing 1.4.4 Others 1.5 Market by Application 1.5.1 Global Preclinical CRO Treatment Market Share by Application: 2020 VS 2026 1.5.2 Biopharmaceutical Companies 1.5.3 Government and Academic Institutes 1.5.4 Medical Device Companies 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Preclinical CRO Treatment Market Perspective (2015-2026) 2.2 Preclinical CRO Treatment Growth Trends by Regions 2.2.1 Preclinical CRO Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Preclinical CRO Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Preclinical CRO Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Preclinical CRO Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key Preclinical CRO Treatment Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Preclinical CRO Treatment Players by Market Size 3.1.1 Global Top Preclinical CRO Treatment Players by Revenue (2015-2020) 3.1.2 Global Preclinical CRO Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global Preclinical CRO Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Preclinical CRO Treatment Market Concentration Ratio 3.2.1 Global Preclinical CRO Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Preclinical CRO Treatment Revenue in 2019 3.3 Preclinical CRO Treatment Key Players Head office and Area Served 3.4 Key Players Preclinical CRO Treatment Product Solution and Service 3.5 Date of Enter into Preclinical CRO Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Preclinical CRO Treatment Historic Market Size by Type (2015-2020) 4.2 Global Preclinical CRO Treatment Forecasted Market Size by Type (2021-2026) 5 Preclinical CRO Treatment Breakdown Data by Application (2015-2026) 5.1 Global Preclinical CRO Treatment Market Size by Application (2015-2020) 5.2 Global Preclinical CRO Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Preclinical CRO Treatment Market Size (2015-2020) 6.2 Preclinical CRO Treatment Key Players in North America (2019-2020) 6.3 North America Preclinical CRO Treatment Market Size by Type (2015-2020) 6.4 North America Preclinical CRO Treatment Market Size by Application (2015-2020) 7 Europe 7.1 Europe Preclinical CRO Treatment Market Size (2015-2020) 7.2 Preclinical CRO Treatment Key Players in Europe (2019-2020) 7.3 Europe Preclinical CRO Treatment Market Size by Type (2015-2020) 7.4 Europe Preclinical CRO Treatment Market Size by Application (2015-2020) 8 China 8.1 China Preclinical CRO Treatment Market Size (2015-2020) 8.2 Preclinical CRO Treatment Key Players in China (2019-2020) 8.3 China Preclinical CRO Treatment Market Size by Type (2015-2020) 8.4 China Preclinical CRO Treatment Market Size by Application (2015-2020) 9 Japan 9.1 Japan Preclinical CRO Treatment Market Size (2015-2020) 9.2 Preclinical CRO Treatment Key Players in Japan (2019-2020) 9.3 Japan Preclinical CRO Treatment Market Size by Type (2015-2020) 9.4 Japan Preclinical CRO Treatment Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Preclinical CRO Treatment Market Size (2015-2020) 10.2 Preclinical CRO Treatment Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Preclinical CRO Treatment Market Size by Type (2015-2020) 10.4 Southeast Asia Preclinical CRO Treatment Market Size by Application (2015-2020) 11 India 11.1 India Preclinical CRO Treatment Market Size (2015-2020) 11.2 Preclinical CRO Treatment Key Players in India (2019-2020) 11.3 India Preclinical CRO Treatment Market Size by Type (2015-2020) 11.4 India Preclinical CRO Treatment Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Preclinical CRO Treatment Market Size (2015-2020) 12.2 Preclinical CRO Treatment Key Players in Central & South America (2019-2020) 12.3 Central & South America Preclinical CRO Treatment Market Size by Type (2015-2020) 12.4 Central & South America Preclinical CRO Treatment Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Charles River Laboratories 13.1.1 Charles River Laboratories Company Details 13.1.2 Charles River Laboratories Business Overview and Its Total Revenue 13.1.3 Charles River Laboratories Preclinical CRO Treatment Introduction 13.1.4 Charles River Laboratories Revenue in Preclinical CRO Treatment Business (2015-2020)) 13.1.5 Charles River Laboratories Recent Development 13.2 Laboratory Corporation of America 13.2.1 Laboratory Corporation of America Company Details 13.2.2 Laboratory Corporation of America Business Overview and Its Total Revenue 13.2.3 Laboratory Corporation of America Preclinical CRO Treatment Introduction 13.2.4 Laboratory Corporation of America Revenue in Preclinical CRO Treatment Business (2015-2020) 13.2.5 Laboratory Corporation of America Recent Development 13.3 Envigo 13.3.1 Envigo Company Details 13.3.2 Envigo Business Overview and Its Total Revenue 13.3.3 Envigo Preclinical CRO Treatment Introduction 13.3.4 Envigo Revenue in Preclinical CRO Treatment Business (2015-2020) 13.3.5 Envigo Recent Development 13.4 Eurofins Scientific 13.4.1 Eurofins Scientific Company Details 13.4.2 Eurofins Scientific Business Overview and Its Total Revenue 13.4.3 Eurofins Scientific Preclinical CRO Treatment Introduction 13.4.4 Eurofins Scientific Revenue in Preclinical CRO Treatment Business (2015-2020) 13.4.5 Eurofins Scientific Recent Development 13.5 PRA Health Science 13.5.1 PRA Health Science Company Details 13.5.2 PRA Health Science Business Overview and Its Total Revenue 13.5.3 PRA Health Science Preclinical CRO Treatment Introduction 13.5.4 PRA Health Science Revenue in Preclinical CRO Treatment Business (2015-2020) 13.5.5 PRA Health Science Recent Development 13.6 Wuxi AppTec 13.6.1 Wuxi AppTec Company Details 13.6.2 Wuxi AppTec Business Overview and Its Total Revenue 13.6.3 Wuxi AppTec Preclinical CRO Treatment Introduction 13.6.4 Wuxi AppTec Revenue in Preclinical CRO Treatment Business (2015-2020) 13.6.5 Wuxi AppTec Recent Development 13.7 Medpace 13.7.1 Medpace Company Details 13.7.2 Medpace Business Overview and Its Total Revenue 13.7.3 Medpace Preclinical CRO Treatment Introduction 13.7.4 Medpace Revenue in Preclinical CRO Treatment Business (2015-2020) 13.7.5 Medpace Recent Development 13.8 Pharmaceutical Product Development 13.8.1 Pharmaceutical Product Development Company Details 13.8.2 Pharmaceutical Product Development Business Overview and Its Total Revenue 13.8.3 Pharmaceutical Product Development Preclinical CRO Treatment Introduction 13.8.4 Pharmaceutical Product Development Revenue in Preclinical CRO Treatment Business (2015-2020) 13.8.5 Pharmaceutical Product Development Recent Development 13.9 Paraxel 13.9.1 Paraxel Company Details 13.9.2 Paraxel Business Overview and Its Total Revenue 13.9.3 Paraxel Preclinical CRO Treatment Introduction 13.9.4 Paraxel Revenue in Preclinical CRO Treatment Business (2015-2020) 13.9.5 Paraxel Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Preclinical CRO Treatment Key Market Segments Table 2. Key Players Covered: Ranking by Preclinical CRO Treatment Revenue Table 3. Ranking of Global Top Preclinical CRO Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Preclinical CRO Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Bioanalysis and DMPK Studies Table 6. Key Players of Toxicology Testing Table 7. Key Players of Others Table 8. Global Preclinical CRO Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Preclinical CRO Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Preclinical CRO Treatment Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Preclinical CRO Treatment Market Share by Regions (2015-2020) Table 12. Global Preclinical CRO Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Preclinical CRO Treatment Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Preclinical CRO Treatment Market Growth Strategy Table 18. Main Points Interviewed from Key Preclinical CRO Treatment Players Table 19. Global Preclinical CRO Treatment Revenue by Players (2015-2020) (Million US$) Table 20. Global Preclinical CRO Treatment Market Share by Players (2015-2020) Table 21. Global Top Preclinical CRO Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preclinical CRO Treatment as of 2019) Table 22. Global Preclinical CRO Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Preclinical CRO Treatment Product Solution and Service Table 25. Date of Enter into Preclinical CRO Treatment Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Preclinical CRO Treatment Market Size by Type (2015-2020) (Million US$) Table 28. Global Preclinical CRO Treatment Market Size Share by Type (2015-2020) Table 29. Global Preclinical CRO Treatment Revenue Market Share by Type (2021-2026) Table 30. Global Preclinical CRO Treatment Market Size Share by Application (2015-2020) Table 31. Global Preclinical CRO Treatment Market Size by Application (2015-2020) (Million US$) Table 32. Global Preclinical CRO Treatment Market Size Share by Application (2021-2026) Table 33. North America Key Players Preclinical CRO Treatment Revenue (2019-2020) (Million US$) Table 34. North America Key Players Preclinical CRO Treatment Market Share (2019-2020) Table 35. North America Preclinical CRO Treatment Market Size by Type (2015-2020) (Million US$) Table 36. North America Preclinical CRO Treatment Market Share by Type (2015-2020) Table 37. North America Preclinical CRO Treatment Market Size by Application (2015-2020) (Million US$) Table 38. North America Preclinical CRO Treatment Market Share by Application (2015-2020) Table 39. Europe Key Players Preclinical CRO Treatment Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Preclinical CRO Treatment Market Share (2019-2020) Table 41. Europe Preclinical CRO Treatment Market Size by Type (2015-2020) (Million US$) Table 42. Europe Preclinical CRO Treatment Market Share by Type (2015-2020) Table 43. Europe Preclinical CRO Treatment Market Size by Application (2015-2020) (Million US$) Table 44. Europe Preclinical CRO Treatment Market Share by Application (2015-2020) Table 45. China Key Players Preclinical CRO Treatment Revenue (2019-2020) (Million US$) Table 46. China Key Players Preclinical CRO Treatment Market Share (2019-2020) Table 47. China Preclinical CRO Treatment Market Size by Type (2015-2020) (Million US$) Table 48. China Preclinical CRO Treatment Market Share by Type (2015-2020) Table 49. China Preclinical CRO Treatment Market Size by Application (2015-2020) (Million US$) Table 50. China Preclinical CRO Treatment Market Share by Application (2015-2020) Table 51. Japan Key Players Preclinical CRO Treatment Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Preclinical CRO Treatment Market Share (2019-2020) Table 53. Japan Preclinical CRO Treatment Market Size by Type (2015-2020) (Million US$) Table 54. Japan Preclinical CRO Treatment Market Share by Type (2015-2020) Table 55. Japan Preclinical CRO Treatment Market Size by Application (2015-2020) (Million US$) Table 56. Japan Preclinical CRO Treatment Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Preclinical CRO Treatment Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Preclinical CRO Treatment Market Share (2019-2020) Table 59. Southeast Asia Preclinical CRO Treatment Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Preclinical CRO Treatment Market Share by Type (2015-2020) Table 61. Southeast Asia Preclinical CRO Treatment Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Preclinical CRO Treatment Market Share by Application (2015-2020) Table 63. India Key Players Preclinical CRO Treatment Revenue (2019-2020) (Million US$) Table 64. India Key Players Preclinical CRO Treatment Market Share (2019-2020) Table 65. India Preclinical CRO Treatment Market Size by Type (2015-2020) (Million US$) Table 66. India Preclinical CRO Treatment Market Share by Type (2015-2020) Table 67. India Preclinical CRO Treatment Market Size by Application (2015-2020) (Million US$) Table 68. India Preclinical CRO Treatment Market Share by Application (2015-2020) Table 69. Central & South America Key Players Preclinical CRO Treatment Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Preclinical CRO Treatment Market Share (2019-2020) Table 71. Central & South America Preclinical CRO Treatment Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Preclinical CRO Treatment Market Share by Type (2015-2020) Table 73. Central & South America Preclinical CRO Treatment Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Preclinical CRO Treatment Market Share by Application (2015-2020) Table 75. Charles River Laboratories Company Details Table 76. Charles River Laboratories Business Overview Table 77. Charles River Laboratories Product Table 78. Charles River Laboratories Revenue in Preclinical CRO Treatment Business (2015-2020) (Million US$) Table 79. Charles River Laboratories Recent Development Table 80. Laboratory Corporation of America Company Details Table 81. Laboratory Corporation of America Business Overview Table 82. Laboratory Corporation of America Product Table 83. Laboratory Corporation of America Revenue in Preclinical CRO Treatment Business (2015-2020) (Million US$) Table 84. Laboratory Corporation of America Recent Development Table 85. Envigo Company Details Table 86. Envigo Business Overview Table 87. Envigo Product Table 88. Envigo Revenue in Preclinical CRO Treatment Business (2015-2020) (Million US$) Table 89. Envigo Recent Development Table 90. Eurofins Scientific Company Details Table 91. Eurofins Scientific Business Overview Table 92. Eurofins Scientific Product Table 93. Eurofins Scientific Revenue in Preclinical CRO Treatment Business (2015-2020) (Million US$) Table 94. Eurofins Scientific Recent Development Table 95. PRA Health Science Company Details Table 96. PRA Health Science Business Overview Table 97. PRA Health Science Product Table 98. PRA Health Science Revenue in Preclinical CRO Treatment Business (2015-2020) (Million US$) Table 99. PRA Health Science Recent Development Table 100. Wuxi AppTec Company Details Table 101. Wuxi AppTec Business Overview Table 102. Wuxi AppTec Product Table 103. Wuxi AppTec Revenue in Preclinical CRO Treatment Business (2015-2020) (Million US$) Table 104. Wuxi AppTec Recent Development Table 105. Medpace Company Details Table 106. Medpace Business Overview Table 107. Medpace Product Table 108. Medpace Revenue in Preclinical CRO Treatment Business (2015-2020) (Million US$) Table 109. Medpace Recent Development Table 110. Pharmaceutical Product Development Business Overview Table 111. Pharmaceutical Product Development Product Table 112. Pharmaceutical Product Development Company Details Table 113. Pharmaceutical Product Development Revenue in Preclinical CRO Treatment Business (2015-2020) (Million US$) Table 114. Pharmaceutical Product Development Recent Development Table 115. Paraxel Company Details Table 116. Paraxel Business Overview Table 117. Paraxel Product Table 118. Paraxel Revenue in Preclinical CRO Treatment Business (2015-2020) (Million US$) Table 119. Paraxel Recent Development Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Global Preclinical CRO Treatment Market Share by Type: 2020 VS 2026 Figure 2. Bioanalysis and DMPK Studies Features Figure 3. Toxicology Testing Features Figure 4. Others Features Figure 5. Global Preclinical CRO Treatment Market Share by Application: 2020 VS 2026 Figure 6. Biopharmaceutical Companies Case Studies Figure 7. Government and Academic Institutes Case Studies Figure 8. Medical Device Companies Case Studies Figure 9. Preclinical CRO Treatment Report Years Considered Figure 10. Global Preclinical CRO Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Preclinical CRO Treatment Market Share by Regions: 2020 VS 2026 Figure 12. Global Preclinical CRO Treatment Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Preclinical CRO Treatment Market Share by Players in 2019 Figure 15. Global Top Preclinical CRO Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preclinical CRO Treatment as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Preclinical CRO Treatment Revenue in 2019 Figure 17. North America Preclinical CRO Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Preclinical CRO Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Preclinical CRO Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Preclinical CRO Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Preclinical CRO Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Preclinical CRO Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Preclinical CRO Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Charles River Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Charles River Laboratories Revenue Growth Rate in Preclinical CRO Treatment Business (2015-2020) Figure 26. Laboratory Corporation of America Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Laboratory Corporation of America Revenue Growth Rate in Preclinical CRO Treatment Business (2015-2020) Figure 28. Envigo Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Envigo Revenue Growth Rate in Preclinical CRO Treatment Business (2015-2020) Figure 30. Eurofins Scientific Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Eurofins Scientific Revenue Growth Rate in Preclinical CRO Treatment Business (2015-2020) Figure 32. PRA Health Science Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. PRA Health Science Revenue Growth Rate in Preclinical CRO Treatment Business (2015-2020) Figure 34. Wuxi AppTec Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Wuxi AppTec Revenue Growth Rate in Preclinical CRO Treatment Business (2015-2020) Figure 36. Medpace Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Medpace Revenue Growth Rate in Preclinical CRO Treatment Business (2015-2020) Figure 38. Pharmaceutical Product Development Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Pharmaceutical Product Development Revenue Growth Rate in Preclinical CRO Treatment Business (2015-2020) Figure 40. Paraxel Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Paraxel Revenue Growth Rate in Preclinical CRO Treatment Business (2015-2020) Figure 42. Bottom-up and Top-down Approaches for This Report Figure 43. Data Triangulation Figure 44. Key Executives Interviewed

Charles River Laboratories Laboratory Corporation of America Envigo Eurofins Scientific PRA Health Science Wuxi AppTec Medpace Pharmaceutical Product Development Paraxel